Bausch + Lomb Corporation (TSX: BLCO)

Canada flag Canada · Delayed Price · Currency is CAD
19.92
-0.84 (-4.05%)
May 17, 2024, 3:59 PM EDT
-25.00%
Market Cap 6.99B
Revenue (ttm) 5.87B
Net Income (ttm) -458.91M
Shares Out 351.52M
EPS (ttm) -1.31
PE Ratio n/a
Forward PE 78.74
Dividend n/a
Ex-Dividend Date n/a
Volume 3,326
Open 20.83
Previous Close 20.76
Day's Range 19.92 - 20.83
52-Week Range 18.11 - 28.96
Beta 0.47
Analysts n/a
Price Target n/a
Earnings Date Jul 31, 2024

About Bausch + Lomb

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and ... [Read more]

Sector Healthcare
Founded 1853
Country Canada
Stock Exchange Toronto Stock Exchange
Ticker Symbol BLCO
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

Bausch + Lomb Announces First-Quarter 2024 Results

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its first-quar...

18 days ago - Business Wire

Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentati...

20 days ago - Business Wire

Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced Frontiers in O...

24 days ago - Business Wire

Bausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programs

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its ONE by ONE...

4 weeks ago - Business Wire

Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter...

4 weeks ago - Business Wire

Bausch + Lomb Stock Jumps After Better-Than-Expected Earnings, Guidance (Investopedia)

A big jump in pharmaceutical sales helped eye-care products maker Bausch + Lomb Corp. beat profit and sales estimates for the fourth quarter.

3 months ago - Investopedia

Eye Care-Focused Bausch + Lomb's Stock Surges On Upbeat Annual Guidance Despite Deeper Losses

Bausch + Lomb Corp (NYSE: BLCO) reported the fourth quarter of 2023 sales of $1.173 billion, up 18% year-on-year (Y/Y), beating the consensus of $1.02 billion . Excluding the unfavorable impact of fo...

3 months ago - Benzinga

Bausch & Lomb's stock soars 11% after earnings beat

Bausch + Lomb Corp.'s stock soared 10% early Wednesday, after the vision-care company's adjusted fourth-quarter profit topped estimates and it offered upbeat revenue guidance for 2024.

3 months ago - Market Watch

Bausch + Lomb Corp at JPMorgan Healthcare Conference Transcript

Bausch + Lomb Corp at JPMorgan Healthcare Conference Transcript

3 months ago - GuruFocus

Bausch + Lomb Corp at Morgan Stanley Global Healthcare Conference Transcript

Bausch + Lomb Corp at Morgan Stanley Global Healthcare Conference Transcript

3 months ago - GuruFocus

Earnings Preview: What To Expect To When Eye Health Company Bausch + Lomb Reports Q4 Performance Later This Month

Eye health products company Bausch + Lomb Corp (NYSE: BLCO) is scheduled to release its fourth-quarter and full-year 2023 financial results on February 21, 2024. According to data from Benzinga Pro ,...

3 months ago - Benzinga

Bausch + Lomb (BLCO) Reports Q3 Earnings: What Key Metrics Have to Say

The headline numbers for Bausch + Lomb (BLCO) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Stree...

7 months ago - Zacks Investment Research

Bausch + Lomb (BLCO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Bausch + Lomb (BLCO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

7 months ago - Zacks Investment Research

Is the Options Market Predicting a Spike in Bausch + Lomb (BLCO) Stock?

Investors need to pay close attention to Bausch + Lomb (BLCO) stock based on the movements in the options market lately.

8 months ago - Zacks Investment Research

Bausch + Lomb Will Participate at the 2023 Wells Fargo Healthcare Conference

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman ...

9 months ago - Business Wire

Bausch + Lomb (BLCO) Beats Q2 Earnings and Revenue Estimates

Bausch + Lomb (BLCO) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.29 per share a year ago.

10 months ago - Zacks Investment Research

BLCO or DOCS: Which Is the Better Value Stock Right Now?

Investors interested in Medical Services stocks are likely familiar with Bausch + Lomb (BLCO) and Doximity (DOCS). But which of these two stocks is more attractive to value investors?

11 months ago - Zacks Investment Research

Bausch Health's Bausch + Lomb to Acquire Novartis' XIIDRA(R)

LAVAL, QC / ACCESSWIRE / June 30, 2023 / Bausch + Lomb Corporation (NYSE/TSX:BLCO), a subsidiary of Bausch Health Companies Inc. (NYSE/TSX:BHC), announced that it has entered into a definitive agreeme...

11 months ago - Accesswire

20 Stocks That Look Like They're in Bubble Territory Right Now

Stocks that are difficult to sell short are likely to be overvalued, a new study finds. These fit the bill.

11 months ago - Barrons

Bausch + Lomb (BLCO) Q1 Earnings Lag Estimates

Bausch + Lomb (BLCO) came out with quarterly earnings of $0.10 per share, missing the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.24 per share a year ago.

1 year ago - Zacks Investment Research

Bausch + Lomb and Heidelberg Engineering Announce the Introduction of SeeLuma™ Fully Digital Surgical Visualization Platform

VAUGHAN, Ontario & HEIDELBERG, Germany--(BUSINESS WIRE)--Bausch + Lomb, a leading global eye health company dedicated to helping people see better to live better, and Heidelberg Engineering, today ann...

1 year ago - Business Wire

Bausch + Lomb Appoints Bob Bailey as Executive Vice President and Chief Legal Officer and Andrew Stewart as President, Ophthalmic Pharmaceuticals

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live bet...

1 year ago - Business Wire

SparingVision appoints Joseph C. Papa as Chairman

SparingVision appoints Jo seph C. Papa as Chairman

1 year ago - GlobeNewsWire

Bausch + Lomb beats Q4 profit and revenue estimates

Bausch + Lomb Corp. BLCO, -2.01% said Wednesday it had a loss of $1 million, or breakeven on a per-share basis, for the fourth quarter, after earnings of $51 million, or 15 cents a share, in the year-...

1 year ago - Market Watch

Bausch + Lomb Announces Fourth-Quarter and Full-Year 2022 Results

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”, “we” or “our”), a leading global eye health company dedicated to helping people see be...

1 year ago - Business Wire